These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


543 related items for PubMed ID: 9449948

  • 1. Evaluation of immunogenicity and protective activity in BALB/c mice of the 25-kDa major outer-membrane protein of Brucella melitensis (Omp25) expressed in Escherichia coli.
    Bowden RA, Cloeckaert A, Zygmunt MS, Dubray G.
    J Med Microbiol; 1998 Jan; 47(1):39-48. PubMed ID: 9449948
    [Abstract] [Full Text] [Related]

  • 2. Immunogenic properties of Brucella melitensis cell-wall fractions in BALB/c mice.
    Cloeckaert A, Jacques I, Limet JN, Dubray G.
    J Med Microbiol; 1995 Mar; 42(3):200-8. PubMed ID: 7884802
    [Abstract] [Full Text] [Related]

  • 3. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M, Rafati S, Siadat SD, Nejati-Moheimani M, Shahcheraghi F, Arsang A, Bouzari S.
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R, Francia M, Ciuchini F.
    Vaccine; 2008 Sep 08; 26(38):4913-7. PubMed ID: 18675869
    [Abstract] [Full Text] [Related]

  • 5. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A, Jacques I, Grilló MJ, Marín CM, Grayon M, Blasco JM, Verger JM.
    Vaccine; 2004 Jul 29; 22(21-22):2827-35. PubMed ID: 15246618
    [Abstract] [Full Text] [Related]

  • 6. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.
    Estein SM, Cassataro J, Vizcaíno N, Zygmunt MS, Cloeckaert A, Bowden RA.
    Microbes Infect; 2003 Feb 29; 5(2):85-93. PubMed ID: 12650766
    [Abstract] [Full Text] [Related]

  • 7. Characterization of O-polysaccharide specific monoclonal antibodies derived from mice infected with the rough Brucella melitensis strain B115.
    Cloeckaert A, Zygmunt MS, Dubray G, Limet JN.
    J Gen Microbiol; 1993 Jul 29; 139(7):1551-6. PubMed ID: 7690392
    [Abstract] [Full Text] [Related]

  • 8. Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection.
    Yang Y, Yin J, Guo D, Lang X, Wang X.
    FEMS Immunol Med Microbiol; 2011 Mar 29; 61(2):159-67. PubMed ID: 21166726
    [Abstract] [Full Text] [Related]

  • 9. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH.
    Infect Immun; 2005 Dec 29; 73(12):8079-88. PubMed ID: 16299302
    [Abstract] [Full Text] [Related]

  • 10. Production and characterisation of monoclonal antibodies to Brucella melitensis cytosoluble proteins that are able to differentiate antibody responses of infected sheep from Rev. 1 vaccinated sheep.
    Cloeckaert A, Debbarh HS, Zygmunt MS, Dubray G.
    J Med Microbiol; 1996 Sep 29; 45(3):206-13. PubMed ID: 8810948
    [Abstract] [Full Text] [Related]

  • 11. Brucella melitensis cell envelope protein and lipopolysaccharide epitopes involved in humoral immune responses of naturally and experimentally infected sheep.
    Zygmunt MS, Cloeckaert A, Dubray G.
    J Clin Microbiol; 1994 Oct 29; 32(10):2514-22. PubMed ID: 7529242
    [Abstract] [Full Text] [Related]

  • 12. Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.
    Al-Mariri A, Mahmoud NH, Hammoud R.
    Biologicals; 2012 Mar 29; 40(2):140-5. PubMed ID: 22296786
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen.
    Yousefi S, Abbassi-Daloii T, Sekhavati MH, Tahmoorespur M.
    Microb Pathog; 2018 Feb 29; 115():50-56. PubMed ID: 29253594
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity of recombinant Escherichia coli expressing the omp31 gene of Brucella melitensis in BALB/c mice.
    Guilloteau LA, Laroucau K, Vizcaíno N, Jacques I, Dubray G.
    Vaccine; 1999 Jan 28; 17(4):353-61. PubMed ID: 9987174
    [Abstract] [Full Text] [Related]

  • 15. The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes.
    Commander NJ, Spencer SA, Wren BW, MacMillan AP.
    Vaccine; 2007 Jan 02; 25(1):43-54. PubMed ID: 17049676
    [Abstract] [Full Text] [Related]

  • 16. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A, Jeddi-Tehrani M, Mautner J, Salari MH, Zarnani AH.
    Vaccine; 2014 Nov 20; 32(49):6659-66. PubMed ID: 25240754
    [Abstract] [Full Text] [Related]

  • 17. Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis.
    Lindler LE, Hadfield TL, Tall BD, Snellings NJ, Rubin FA, Van De Verg LL, Hoover D, Warren RL.
    Infect Immun; 1996 Jul 20; 64(7):2490-9. PubMed ID: 8698471
    [Abstract] [Full Text] [Related]

  • 18. Characterization of an immuno-dominant antigen in Brucella ovis and evaluation of its use in an enzyme-linked immunosorbent assay.
    Kittelberger R, Diack DS, Vizcaíno N, Zygmunt MS, Cloeckaert A.
    Vet Microbiol; 1998 Jan 16; 59(2-3):213-27. PubMed ID: 9549861
    [Abstract] [Full Text] [Related]

  • 19. Protection of BALB/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein.
    Al-Mariri A.
    Vaccine; 2010 Feb 17; 28(7):1766-70. PubMed ID: 20036752
    [Abstract] [Full Text] [Related]

  • 20. Nucleotide sequence and expression of the gene encoding the major 25-kilodalton outer membrane protein of Brucella ovis: Evidence for antigenic shift, compared with other Brucella species, due to a deletion in the gene.
    Cloeckaert A, Verger JM, Grayon M, Zygmunt MS, Grépinet O.
    Infect Immun; 1996 Jun 17; 64(6):2047-55. PubMed ID: 8675306
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.